Grufity logo
Grufity logo

Latest Ikarian Capital, LLC Stock Portfolio

$928Million | No. of Holdings #127

Ikarian Capital, LLC Performance

2026 Q2+3.71%
YTD+3.33%
2025+26.73%

About Ikarian Capital, LLC and 13F Hedge Fund Stock Holdings

Ikarian Capital, LLC is a hedge fund based in Dallas, TX. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Ikarian Capital, LLC reported an equity portfolio of $928.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Ikarian Capital, LLC are , KOD, . The fund has invested 4.7% of it's portfolio in ABIVAX SA and 4.4% of portfolio in KODIAK SCIENCES INC. <br><br> The fund managers got completely rid off TERNS PHARMACEUTICALS INC (TERN), CYTOKINETICS INC (CYTK) and REVOLUTION MEDICINES INC (RVMD) stocks. They significantly reduced their stock positions in COMPASS PATHWAYS PLC (CMPS), SOLID BIOSCIENCES INC (SLDB) and FORTE BIOSCIENCES INC (FBRX). Ikarian Capital, LLC opened new stock positions in ARCUS BIOSCIENCES INC (RCUS), COGENT BIOSCIENCES INC (COGT) and C4 THERAPEUTICS INC (CCCC). The fund showed a lot of confidence in some stocks as they added substantially to REZOLUTE INC (RZLT), ABIVAX SA and FAETH THERAPEUTICS INC (SNSE).
Ikarian Capital, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$928Million
  as of Aug 14, 2026

Ikarian Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Ikarian Capital, LLC made a return of 3.71% in the last quarter. In trailing 12 months, it's portfolio return was 52.69%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
arcus biosciences inc15,555,600
cogent biosciences inc14,322,300
c4 therapeutics inc11,362,100
viridian therapeutics inc7,807,250
hims & hers health inc6,531,170
enliven therapeutics inc6,421,960
kazia therapeutics ltd5,578,510
q32 bio inc5,478,200
New stocks bought by Ikarian Capital, LLC

Additions

Ticker% Inc.
rezolute inc5,573
abivax sa470
faeth therapeutics inc457
promis neurosciences inc272
cns pharmaceuticals inc196
palisade bio inc172
proqr thrapeutics n v129
ani pharmaceuticals inc84.98
Additions to existing portfolio by Ikarian Capital, LLC

Reductions

Ticker% Reduced
compass pathways plc-97.78
solid biosciences inc-83.75
forte biosciences inc-82.37
harrow inc-75.00
ultragenyx pharmaceutical in-65.68
bridgebio pharma inc-64.14
delcath sys inc-56.95
anteris technologies global-54.56
Ikarian Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
terns pharmaceuticals inc-76,780,200
io biotech inc-81,391
sangamo therapeutics inc-300,890
soleno therapeutics inc-11,521,200
vir biotechnology inc-2,627,590
cytokinetics inc-18,690,200
bridgebio oncology therapeut-2,418,570
oruka therapeutics inc-11,871,100
Ikarian Capital, LLC got rid off the above stocks

Sector Distribution

Ikarian Capital, LLC has about 61.3% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Consumer Defensive
Sector%
Healthcare61.3
Others37.3
Consumer Defensive1.1

Market Cap. Distribution

Ikarian Capital, LLC has about 1.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • MICRO-CAP
  • LARGE-CAP
Category%
UNALLOCATED37.3
MID-CAP29
SMALL-CAP24.3
MICRO-CAP7.5
LARGE-CAP1.2

Stocks belong to which Index?

About 35.9% of the stocks held by Ikarian Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others64.1
RUSSELL 200035.9
Top 5 Winners (%)%
CPIX
cumberland pharmaceuticals i
94.9 %
CMPS
compass pathways plc
79.7 %
fractyl health inc
73.5 %
SELB
cartesian therapeutics inc
69.4 %
adlai nortye ltd
66.2 %
Top 5 Winners ($)$
alumis inc
6.4 M
abivax sa
4.6 M
RARE
ultragenyx pharmaceutical in
4.0 M
AVTE
jade biosciences inc
3.8 M
biohaven ltd
3.7 M
Top 5 Losers (%)%
PHGE
biomx inc
-90.7 %
NXTC
nextcure inc
-83.6 %
LPCN
lipocine inc new
-68.0 %
AEMD
aethlon med inc
-62.4 %
VSTA
vistagen therapeutics inc
-60.5 %
Top 5 Losers ($)$
FULC
fulcrum therapeutics inc
-4.2 M
CAPR
capricor therapeutics inc
-3.6 M
LPCN
lipocine inc new
-2.8 M
NXTC
nextcure inc
-2.3 M
IVA
inventiva sa
-2.3 M

Ikarian Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Ikarian Capital, LLC

Ikarian Capital, LLC has 127 stocks in it's portfolio. About 26% of the portfolio is in top 10 stocks. FULC proved to be the most loss making stock for the portfolio. was the most profitable stock for Ikarian Capital, LLC last quarter.

$610.87MTotal Value
152Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Ikarian Capital, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change